Pricing Log in Create free account
Friday 6 November 2026 Export LIVN’s income statement to Excel — free account

LivaNova PLC

LIVN Healthcare Medical Devices

LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024.

Revenue
+9.88%
EPS
+27.4%
Free cash flow
−31.0%
Total debt
−31.2%

Quarter to September 2026, against a year earlier

90.87 0.27 −0.30%
Market cap
$5.0B
P/E
25.6×
Fwd P/E
19.8×
Dividend yield
—
F-score
4/9
Altman Z
1.74
Beneish M
−3.30
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

LivaNova PLC (LIVN) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, LivaNova PLC (LIVN) trades at a EV/EBITDA of 17.6×. Over the past ten years it has ranged from 0.0× (December 2021) to 271× (February 2024); the current reading is higher than 62% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 11.0× (8.28%)
FY2024 12.0× (95.00%)
FY2023 240× 960.86%
FY2022 22.6× (57.51%)
FY2021 53.2× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 18.5× 31.18%
FY2016 14.1× (72.50%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 14.5× (8.06%)
Jun 2026 15.8× 34.42%
Mar 2026 11.7× 6.79%
Dec 2025 11.0× 13.75%
45 more quarters

Against its own ten years

Low 0.0× High 271×
Ten-year median 13.1×
Current reading's percentile 62

EV/EBITDA against peers

Company EV/EBITDA
BIO Bio-Rad Laboratories, Inc. compare n/m
AXGN AxoGen, Inc. compare n/m
TXG 10x Genomics compare n/m
LIVN LivaNova PLC 17.6×
ITGR Integer Holdings Corporation compare 18.8×
HAE Haemonetics Corporation compare 23.6×
NEOG Neogen Corporation compare 27.2×
BRKR Bruker Corporation compare 66.0×
IRTC iRhythm Holdings, Inc. compare 2,944×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on LIVN